Charles River Laboratories International CRL
NYSE CRL
$296.78 +1.68 (+0.57%)
As of: Aug 27, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Revenue Growth (1y) (2010 - 2026)

Charles River Laboratories International (CRL) Revenue Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 10.49%
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 5.54%
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 37.71%
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 10.01%
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 8.74%
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 9.66%
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 9.44%
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 4.48%
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 5.78%
10 Charles River Laboratories International 14.28 Bn 14.09 Bn 452.07 Mn -2.72%

Historic Data

Download Data
DateValue
Jun 27, 2026 -2.72%
Dec 27, 2025 -0.83%
Sep 27, 2025 -0.49%
Jun 28, 2025 0.59%
Mar 29, 2025 -2.71%
Dec 28, 2024 -1.08%
Sep 28, 2024 -1.64%
Jun 29, 2024 -3.19%
Mar 30, 2024 -1.73%
Dec 30, 2023 -7.85%
Sep 30, 2023 3.79%
Jul 1, 2023 8.92%
Apr 1, 2023 12.63%
Dec 31, 2022 21.52%
Sep 24, 2022 10.40%
Jun 25, 2022 6.40%
Mar 26, 2022 10.84%
Dec 25, 2021 14.42%
Sep 25, 2021 20.54%
Jun 26, 2021 33.99%